S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

ArrowMark Financial (BANX) Competitors

$18.07
-0.24 (-1.31%)
(As of 04/17/2024 ET)

BANX vs. OFS, SPE, JHI, DHF, VBF, VTN, GROW, EMD, FGBI, and UBFO

Should you be buying ArrowMark Financial stock or one of its competitors? The main competitors of ArrowMark Financial include OFS Capital (OFS), Special Opportunities Fund (SPE), John Hancock Investors Trust (JHI), BNY Mellon High Yield Strategies Fund (DHF), Invesco Bond Fund (VBF), Invesco Trust for Investment Grade New York Municipals (VTN), U.S. Global Investors (GROW), Western Asset Emerging Markets Debt Fund (EMD), First Guaranty Bancshares (FGBI), and United Security Bancshares (UBFO).

ArrowMark Financial vs.

ArrowMark Financial (NASDAQ:BANX) and OFS Capital (NASDAQ:OFS) are both small-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, earnings, profitability, analyst recommendations, dividends, valuation, risk and community ranking.

ArrowMark Financial received 29 more outperform votes than OFS Capital when rated by MarketBeat users. Likewise, 72.27% of users gave ArrowMark Financial an outperform vote while only 59.64% of users gave OFS Capital an outperform vote.

CompanyUnderperformOutperform
ArrowMark FinancialOutperform Votes
258
72.27%
Underperform Votes
99
27.73%
OFS CapitalOutperform Votes
229
59.64%
Underperform Votes
155
40.36%

ArrowMark Financial has higher earnings, but lower revenue than OFS Capital.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ArrowMark Financial$17.36M7.38$12.63MN/AN/A
OFS Capital$56.94M2.25-$470K-$0.04-239.50

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ArrowMark Financial
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
OFS Capital
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, OFS Capital had 6 more articles in the media than ArrowMark Financial. MarketBeat recorded 7 mentions for OFS Capital and 1 mentions for ArrowMark Financial. OFS Capital's average media sentiment score of 0.32 beat ArrowMark Financial's score of 0.00 indicating that OFS Capital is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ArrowMark Financial
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
OFS Capital
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

24.9% of ArrowMark Financial shares are owned by institutional investors. Comparatively, 10.8% of OFS Capital shares are owned by institutional investors. 0.5% of ArrowMark Financial shares are owned by insiders. Comparatively, 0.5% of OFS Capital shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

ArrowMark Financial has a net margin of 0.00% compared to OFS Capital's net margin of -0.82%. OFS Capital's return on equity of 11.76% beat ArrowMark Financial's return on equity.

Company Net Margins Return on Equity Return on Assets
ArrowMark FinancialN/A N/A N/A
OFS Capital -0.82%11.76%4.10%

ArrowMark Financial has a beta of 0.44, indicating that its stock price is 56% less volatile than the S&P 500. Comparatively, OFS Capital has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500.

ArrowMark Financial pays an annual dividend of $1.80 per share and has a dividend yield of 10.0%. OFS Capital pays an annual dividend of $1.36 per share and has a dividend yield of 14.2%. OFS Capital pays out -3,400.0% of its earnings in the form of a dividend.

Summary

OFS Capital beats ArrowMark Financial on 8 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BANX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BANX vs. The Competition

MetricArrowMark FinancialInvestment advice IndustryFinance SectorNASDAQ Exchange
Market Cap$128.19M$8.78B$8.06B$7.44B
Dividend Yield9.77%24.17%10.56%3.97%
P/E RatioN/A22.8956.6914.66
Price / Sales7.386.693,567.0088.05
Price / CashN/A14.7127.1635.32
Price / BookN/A3.582.344.24
Net Income$12.63M$301.42M$987.46M$211.53M
7 Day Performance-2.59%-3.15%-1.82%-3.92%
1 Month Performance-6.19%-1.09%-2.42%-2.99%
1 Year Performance-1.90%16.83%8.71%5.13%

ArrowMark Financial Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OFS
OFS Capital
0.3607 of 5 stars
$9.50
-0.3%
N/A-5.2%$127.30M$56.94M-237.5051
SPE
Special Opportunities Fund
0 of 5 stars
$12.16
-1.6%
N/A+9.6%$135.95MN/A0.00N/A
JHI
John Hancock Investors Trust
0 of 5 stars
$12.99
-0.1%
N/A+1.7%$113.53MN/A0.00N/APositive News
DHF
BNY Mellon High Yield Strategies Fund
0 of 5 stars
$2.27
-0.4%
N/A+2.7%$165.11M$23.21M0.00N/A
VBF
Invesco Bond Fund
0 of 5 stars
$15.08
-0.1%
N/A-4.4%$172.21MN/A0.00N/APositive News
VTN
Invesco Trust for Investment Grade New York Municipals
0 of 5 stars
$10.49
+0.2%
N/A+1.9%$204.35MN/A0.00N/APositive News
GROW
U.S. Global Investors
2.4718 of 5 stars
$2.78
-0.4%
N/A-3.5%$39.28M$15.07M12.0921News Coverage
EMD
Western Asset Emerging Markets Debt Fund
0 of 5 stars
$8.92
-1.0%
N/A+0.2%$255.24M$72.56M0.00N/A
FGBI
First Guaranty Bancshares
4.4894 of 5 stars
$9.94
-1.7%
$11.25
+13.2%
-29.7%$124.35M$193.59M16.03486Positive News
UBFO
United Security Bancshares
3.5684 of 5 stars
$7.16
-1.4%
N/A+18.9%$124.01M$65.95M6.17114Upcoming Earnings
Positive News

Related Companies and Tools

This page (NASDAQ:BANX) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners